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Keratinocyte growth factor accelerates compensatory growth in the
remaining lung after trilobectomy in rats
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Objective: In rats pulmonary resection is followed by lung compensatory growth. However, the molecular mech-
anism underlying lung compensatory growth remains unclear. Keratinocyte growth factor is expressed in lung
tissue and is considered a possible mitogen for lung epithelial cells. The objectives of this study were to define
the role of keratinocyte growth factor and its receptor in rat lung compensatory growth after trilobectomy and
the effect of exogenous keratinocyte growth factor gene transfection.
Methods: Adult Lewis rats were used. Right trilobectomy was performed in the operation group and sham tho-
racotomy in the sham group. In the operation group, keratinocyte growth factor–FLAG or FLAG expression vec-
tor was transfected directly into the lung by means of electroporation. Expression of keratinocyte growth factor
and its receptor and alveolar cell proliferation index based on proliferating cell nuclear antigen levels were mea-
sured in the right lung at day 14 after the operation.
Results: Proliferating cell nuclear antigen, keratinocyte growth factor, and keratinocyte growth factor receptor
expression in lung epithelial cells was significantly increased at day 4 after trilobectomy. Transfection of kerati-
nocyte growth factor–FLAG expression vector resulted in further significant enhancement of proliferating cell
nuclear antigen at day 4 after trilobectomy; however, the transfection of FLAG expression vector did not alter
the enhancement of proliferating cell nuclear antigen. Exogenous expression of keratinocyte growth factor in
the remaining lung by means of electroporation significantly augmented epithelial proliferation and decreased
the average airspace distance (mean linear intercept).
Conclusion: Our results implicate keratinocyte growth factor in the induction of alveolar epithelial cell prolifer-
ation for compensatory lung growth and indicate that overexpression of keratinocyte growth factor in the remain-
ing lung by means of electroporation significantly augmented lung epithelial proliferation.
EVOLVING TECHNOLOGYE
TThe lung undergoes compensatory growth after lung injury
or surgical resection. The growth process involves increas-
ing lung volume, weight, cell proliferation, and pulmonary
function,1,2 but the mechanism responsible for this process
is unclear. Understanding lung compensatory growth re-
quires clarification of the molecular mechanism underlying
the induction of lung epithelial cell proliferation.
Rubin and colleagues3 discovered keratinocyte growth
factor (KGF) as a mesenchymal cell–derived epithelial cell
mitogen, and subsequently the KGF receptor (KGFR; bek
IIIb) was identified in various epithelial cells. KGF expres-
sion is upregulated in rodent models of lung injury and
has been implicated in the induction of alveolar epithelial
cell proliferation.4 Kaza and associates5 demonstrated that
exogenous KGF enhanced postpneumonectomy compensa-
tory lung growth through alveolar proliferation. The findings
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doi:10.1016/j.jtcvs.2008.11.037The Journal of Thoracic and Cof that study were significant for investigating the role of ex-
ogenous KGF on lung compensatory growth. However, it is
still unclear whether endogenous KGF and KGFR play a di-
rect role in the induction of lung epithelial proliferation and
differentiation during the compensatory growth of the lung
after lobectomy.
We hypothesized that KGF and KGFR are involved in
compensatory lung growth and that exogenous KGF admin-
istration accelerates the compensatory lung growth. In the
present study we investigated first the temporal and spatial
relationships between the proliferation of lung epithelial
cells and the expression of KGF/KGFR in regenerating rat
lung after trilobectomy by using immunohistochemistry.
In the second part of the study, KGF was expressed in the
remaining lung tissue to examine the effect of prolonged ex-
posure to KGF on lung growth in vivo. For prolonged in situ
expression of KGF in the lung, we used electroporation in
this study because, unlike other methods, it facilitates the in-
troduction of foreign genes into a specific area of the desired
tissue with minimal damage6 and few side effects.
MATERIALS AND METHODS
Animals, Surgical Procedure, and Tissue Preparation
Pathogen-free 8-week-oldmale Lewis rats weighing 220 to 270 g used as
adult rats were purchased from Charles River Japan (Kanagawa, Japan).
Each rat was anesthetized with intraperitoneal injection of 25 mg/kg sodium
pentobarbital. The right lung of rats consists of 4 lobes: the cranial, middle,ardiovascular Surgery c Volume 137, Number 6 1499




HGF ¼ hepatocyte growth factor
hKGF ¼ human keratinocyte growth factor
HRP ¼ horseradish peroxidase
KGF ¼ keratinocyte growth factor
KGFR ¼ keratinocyte growth factor receptor
PCR ¼ polymerase chain reaction
SP-A ¼ surfactant protein-A
accessory and caudal lobes. In the surgery group the right 3 lobes (cranial,
middle, and accessory lobe) were excised by means of thoracotomy, and the
remaining caudal lobewas used for investigation. In the shamgroup a simple
right thoracotomy was performed. Each experimental group at a given time
point consisted of 3 rats. The remaining lung lobe after trilobectomy and
sham operation was dissected out and fixed in 4% paraformaldehyde
(Merck, Darmstadt, Germany). Serial 4-mm sections were cut, and each
specimen was stained with hematoxylin and eosin. All animal experiments
were performed in accordance with National Institutes of Health guidelines
dictated by the Animal Care Facility at Nagasaki University Graduate
School of Medicine (approval code 0309010318).
Cells
L2 rat lung epithelial cells (ATCC, Manassas, Va) were grown in F12K
medium (Sigma, St Louis, Mo) supplemented with 100 U/mL penicillin,
100mg/mLstreptomycin, and 10% fetal bovine serumat 37Cand5%CO2.
Construction of a Recombinant Plasmid Encoding
Human KGF
The humanKGF (hKGF) coding region was amplified bymeans of poly-
merase chain reaction (PCR), with pCEV9 plasmid (kindly provided by Jef-
frey Rubin, National Cancer Institute, Bethesda, Md) as a template. This
plasmid contains the complete KGF coding sequence isolated from an
M426 human embryonic lung fibroblast cDNA library.7 The sequences of
forward and reverse primers were 50-CCTAGATCTGCCACCATGCA
CAAATGGATACTGAC-30 and 50-CCTCTCGAGTTAAGTTATTGC
CATAGGAAG-30, respectively. The forward primer is homologous to nu-
cleotides 1 to 20 in the hKGF open reading frame and contains a consensus
(GCCACC) Kozak sequence immediately upstream of the initiation codon.
In addition, a BglII site was inserted at the 50-end to facilitate cloning. The
reverse primer is homologous to nucleotides 563 to 582 and contains an
XbaI site at the 50-terminus. These primers allowed amplification of
a 603-bp cDNA fragment. PCR was carried out in a reaction mixture con-
taining 2 mmol/L Tris–HCl (pH 8.0), 10 mmol/L KCl, 2 mmol/L MgCl2,
0.01 mmol/L ethylenediamine tetra-acetic acid, 0.1 mmol/L dithiothreitol,
0.05% Tween 20, 0.05% Nonidet P-40, 5% glycerol, 0.25 mmol/L deox-
yribonucleoside triphosphate mixture, 100 pmol of each primer, 6 mg of
pCEV9 DNA, and 3 U of Taq polymerase (Takara Mirus Bio Co, Shiga, Ja-
pan). Before cycling, the mixture was divided into four 20-mL reaction vol-
umes. PCR assays were performed in a Gene Amp PCR system 9600
(Perkin Elmer, Foster City, Calif) for 27 cycles under the following condi-
tions: 94C for 30 seconds, 54C for 30 seconds, and 72C for 1 minute,
followed by a final extension at 72C for 15 minutes. Agarose gel electro-
phoresis with a Qiagen Gel Extraction Kit (Qiagen, Hilden, Germany) was
used to purify the amplified product. The recovered DNA was then cloned
into the plasmid pGEM-T Easy Vector by using the pGEM-T Easy Vector
System I (Promega, Madison, Wis), resulting in the pGEM–hKGF plasmid.
We then isolated the DNA insert containing the hKGF sequence from
pGEM–hKGF by using double digestion with BglII and XbaI and further1500 The Journal of Thoracic and Cardiovascular Susubcloned into the p3xFLAG–CMV14 vector (Sigma) at the same restric-
tion sites to produce the pKGF–FLAG plasmid. All constructions were con-
firmed by means of automated sequencing (CEQ8000; Beckman Coulter,
Fullerton, Calif).
Evaluation of Lung Cell Proliferation
Lung cell proliferation was analyzed immunohistochemically by using
anti-proliferating cell nuclear antigen (PCNA) antibody (DAKO, Glostrup,
Denmark). Briefly, the sections were autoclaved and incubated with PCNA
(1:200) as the primary antibody and horseradish peroxidase (HRP)–goat
anti-mouse IgG (1:200) (Chemicon International Temecula, Calif) as the
secondary antibody.
Western Blot Analysis of KGF and KGFR Expression
in Transfected Cells and Remaining Lung Tissue
Transfected cells were lysed in 0.3 mL of lysis buffer (50 mmol/L Tris–
HCl [pH 7.4], 150 mmol/L NaCl, 5 mmol/L ethylenediamine tetra-acetic
acid, 1 mmol/L phenylmethylsulfonyl fluoride, 50 mg/mL lima bean trypsin
inhibitor, and 0.5% Triton X-100). Rat lung specimens were homogenized
in lysis and centrifuged, and then the supernatants were collected. Recombi-
nant human KGF (Pepro Tech EC, London, UK) and recombinant human
KGFR (R&D Systems Minneapolis, Minn) were also processed as positive
controls. Samples were separated by means of sodium dodecylsulfate–poly-
acrylamide gel electrophoresis on a 4% to 20% gradient gel (Daiichi Pure
Chemicals, Tokyo, Japan) for KGF or a 10% to 20% gradient gel (Daiichi)
for KGFR and electrophoretically transferred to a polyvinylidene difluoride
membrane (Immobilon; Millipore Corp, Bedford, Mass). The membranes
were blocked with Blocking One (Nacalai tesque, Kyoto, Japan) and then
incubated with the first antibody (1:800 anti-KGF antibody, 1:800 anti-
KGFR antibody; Nichirei Co, Tokyo, Japan; and 1:6000 peroxidase-conju-
gated mouse monoclonal anti-FLAG antibody, Invitrogen, Tokyo, Japan).
After washing, the membranes were reacted with HRP-conjugated goat
anti-rabbit IgG as the secondary antibody at 1:8000 for KGF and 1:4000
for KGFR and were visualized by means of chemiluminescence with the
ECL Plus reagent (Amersham Biosciences, Piscataway, NJ).
Immunohistochemistry of KGF and KGFR in
the Lung
Immunohistochemistry was performed to determine the expression of
KGF and KGFR in tissue sections by using anti-KGF and anti-KGFR anti-
bodies, as described previously.8,9 Sections of rat lung tissue were incubated
for 2 hours with primary antibody at 1.0 mg/mL for the anti-KGF antibody
and 1:600 for anti-KGFR antiserum and then incubated with HRP-conju-
gated goat anti-rabbit IgG (1:100; MBL, Nagoya, Japan) for 1 hour. After
washing, HRP sites were visualized by treatment with 3,30-diaminobenzi-
dine-4HCl (Dojindo, Kumamoto, Japan) and H2O2.
Transfection of KGF Expression Plasmid Into
Cultured Cells and Assay of Cell Proliferation and
KGF Production
L2 cells (23 106 in 200 mL) were resuspended into sterile cuvettes, and
plasmid DNA (10 mg) of pKGF–FLAG or pFLAG genes was added. An
electric pulse (400 V, 99 ms, 5 pulses) was delivered to the cells with
a BTX Transfector apparatus (BTX, Inc, San Diego, Calif). Cells were
plated at a density of 3 3 103 cells/well in 96-well plates at a final volume
of 100 mL/well and cultured in a humidified atmosphere at 37C for analysis
with the Cell Proliferation Biotrak enzyme-linked immunosorbent assay
system (Amersham Biosciences) to determine the biologic activity of
KGF–FLAG fusion protein in vitro. The optical density of each well was
measured at 450 nm.
The cells were plated at a density of 5 3 105 cells/well in 6-well plastic
culture dishes (Iwaki, Tokyo, Japan) in 1 mL of F12K medium (Sigma)rgery c June 2009
Matsumoto et al Evolving TechnologyFIGURE 1. Serial changes in proliferating cell nuclear antigen (PCNA)–positive alveolar epithelial cell counts in the remaining lung. A-F, Immunohisto-
chemical staining for PCNA. (Original magnification 4003.) Bar¼ 50 mm.A, Alveolar part of normal lung. B, Bronchial part of normal lung. C, Alveolar part
at day 4 after trilobectomy. D, Bronchial part at day 4 after trilobectomy. E, Alveolar part at day 4 after the sham operation. F, Bronchial part at day 4 after the
sham operation. G, Serial changes in proliferating cell nuclear antigen labeling index. Open circles, Trilobectomy group (n ¼ 3); filled circles, sham group
(n ¼ 3). *P< .05.E
Tsupplemented with 10% fetal bovine serum per well to measure KGF. After
incubation for 24, 48, or 72 hours, the media were collected, and the cells
were harvested with a lysate buffer (1% sodium dodecylsulfate and 1.0
mmol/L sodium orthovanadate in 10 mmol/L Tris–HCl, pH 7.4). The con-
centration of KGF was determined by means of enzyme-linked immunosor-
bent assay (R&D Systems), according to the instructions provided by the
manufacturer.
In Vivo Transfection of KGF–FLAG and FLAG
Expression Vectors
For tissue transfection, pulses generated with an Electro Square Porator
(T820; BTX, Inc) were delivered to the organ by a pair of electrode disks
(1-cm diameter) attached to the tips of tweezers (Pinsettes-Type electrode
449-10PRG;Meiwa Shoji, Tokyo, Japan). We used a green fluorescent pro-
tein–expressing plasmid to optimize conditions for lung transfection. The
best results were obtained with 6 pulses of 50 V for 50 ms, each separated
by 999 ms, which were delivered by electrode disks separated by approxi-
mately 5 mm (data not shown). After trilobectomy, a solution of 100 mg of
pKGF–FLAG or pFLAG plasmid in 100 mL of PBS was injected directly
with a 29-gauge needle into the remaining lung between the electrode disks.
Immediately after the DNA injection, electric pulses were administered.
Rats were killed 2, 4, or 7 days after electroporation. Each experimental
group consisted of 5 rats at each time point.The Journal of Thoracic and CIdentification of PCNA-Positive and
FLAG-Expressing Cell Types
Double staining for PCNA and surfactant protein-A (SP-A), an alveolar
type II epithelial cell marker, was performed on sections of lung tissue to
identify the types of PCNA-positive cells. The slides were stained first
with anti-SP-A antibody (1:30; Santa Cruz Biotechnology, Santa Cruz, Ca-
lif), and the HRP sites were visualized with 3,30-diaminobenzidine-4HCl
and H2O2. The slides were autoclaved and immersed 3 times with 0.1
mol/L glycine-HCl buffer (pH 2.2) and then immunostained with anti-
PCNA antibody (1:50), as described above. HRP reactivity was visualized
with 4-Cl-1-naphthol (TokyoKasei Kogyo, Tokyo, Japan). Peroxidase-con-
jugatedmousemonoclonal anti-FLAG antibody (1:30, Invitrogen) was used
to identify FLAG-expressing cells.
Quantitative Analysis
The PCNA staining was graded as positive or negative compared with
the negative control. For each section, more than 2000 cell nuclei were
counted over randomly selected fields at 4003 magnification. The num-
ber of positive cells was expressed as the percentage of cells with positive
nuclei per total number of counted nuclei.10 The signal density of KGF
and KGFR per cell was measured by using an image analyzer and calcu-
lated from the sum of the gray values of all pixels corresponding to the
cell.ardiovascular Surgery c Volume 137, Number 6 1501
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TBy using a grid with lines of known length, the average airspace distance
(mean linear intercept) was determined in 30 randomly selected microscopic
fields per rat in pFLAG gene– or pKGF–FLAG gene–transfected groups at
day 7 after the operation. The observers who performed the measurements
were blinded to the experimental groups.
Statistical Analysis
Data are expressed as mean values the standard error of the mean. Dif-
ferences between groups were examined for statistical significance with the
unpaired Student’s t test or 1-way analysis of variance. All analyses were
performed with a statistical software package (StatView, version J5.0; Aba-
cus Concepts, Berkeley, Calif).
RESULTS
Induction of Epithelial Cell Proliferation in
Remaining Lung After Trilobectomy
Proliferating cells were assessed by means of immuno-
chemical staining for PCNA to examine the cell kinetics
of compensatory regenerating lung. A few proliferating cells
were noted in the normal lung (Figure 1, A and B), with
a PCNA labeling index (percentage of proliferative cells
per total cell number) of 1.74%  0.75% for alveolar epi-
thelial cells. At day 4 after trilobectomy, several PCNA-pos-
itive bronchial and alveolar epithelial cells were noted
(Figure 1, C and D), with a PCNA labeling index of 8.49
 1.83 for alveolar epithelial cells. In the sham-operated
lungs, few PCNA-positive bronchial and alveolar epithelial
cells were detected (Figure 1, E and F), with a PCNA label-
ing index of 1.99 0.61 for alveolar epithelial cells. Most of
the positive cells in the alveolar regions of rats undergoing
trilobectomy seemed to be alveolar type II epithelial cells
(Figure 1, C). As shown in Figure 1, G, the percentage of
PCNA-positive cells increased significantly at day 2 and
reached a maximum at day 4 after the operation in the trilo-
bectomy group. Many PCNA-positive cells were alveolar
type II cells (Figure 1, C); however, some alveolar type I
cells, macrophages, fibroblasts, and bronchial epithelial cells
were PCNA positive.
Western Blot Analysis of KGF and KGFR Expression
in Remaining Lung After Trilobectomy
Western blot analysis showed specific bands correspond-
ing to KGF and KGFR proteins at approximately 28 and
130 kd, respectively.3,11,12 The approximate molecular
mass of 130 kd is in agreement with the reported molecular
mass of the mature KGFR.11-13 Recombinant human KGF
is an 18.9-kd protein containing 163 amino acid residues
but has the same function as endogenous KGF. The reduced
human KGFR has a calculated molecular mass of approxi-
mately 56 kd. As a result of glycosylation, the recombinant
protein migrates as an approximately 100-kd protein in so-
dium dodecylsulfate–polyacrylamide gel electrophoresis.
The intensity levels of the KGF and KGFR bands in the re-
maining lung markedly increased at day 4 after trilobectomy1502 The Journal of Thoracic and Cardiovascular Sucompared with those seen in the sham-operated group
(Figure 2).
Immunohistochemical Localization of KGF and
KGFR in Remaining Lung After Trilobectomy
Normal lung tissue collected after the sham operation
showed KGF protein expression only in a few stromal cells
and alveolar epithelial cells, particularly alveolar type II cells
(data not shown). KGFR was also found in only a few epi-
thelial cells. The expression of both KGF and KGFR in-
creased after trilobectomy compared with that seen in the
sham-operated lungs (Figure 3, B andD) and reached a max-
imum in the alveolar (Figure 3, A and C) and bronchial (Fig-
ure 3, E and F) regions at day 4 after the operation. KGF was
expressed strongly in stromal cells and alveolar type I and
type II cells, whereas KGFRwas expressed only in epithelial
cells, especially alveolar type II cells, where the signal was
distributed in the cytoplasm and plasma membrane. KGF
expression increased as early as day 2 after trilobectomy in
the remaining lung (signal density in the operation group,
3.92  1.05-fold; sham operation group, 1.05  1.11-fold;
P<.05) and reached a maximum at day 4 after the operation
(signal density in the operation group, 9.16  4.38-fold;
sham operation group, 0.84  0.33-fold; P<.05), as shown
in Figure 3, G. Similarly, KGFR expression reached a max-
imum at day 4 after trilobectomy (signal density in the oper-
ation group, 22.96  13.6-fold; sham operation group, 0.91
 0.30-fold; P< .05), as shown in Figure 3, H.
To clarify the relationship between PCNA-positive cells
and KGF- or KGFR-positive cells, these antigens were lo-
calized in serial sections (Figure 4). KGF and KGFR were
detected in both alveolar type I and type II cells, whereas
PCNA was localized in alveolar type II cells.
FIGURE 2. Western blot analysis of keratinocyte growth factor and kera-
tinocyte growth factor receptor in the remaining lung. Recombinant human
keratinocyte growth factor protein (lane 1) and lysates of remaining lung at
day 4 after trilobectomy (lane 2) and after the sham operation (lane 3) are
shown. Recombinant human keratinocyte growth factor receptor protein
(lane 4) and lysates of remaining lung at day 4 after trilobectomy (lane 5)
and after the sham operation (lane 6) are also shown.rgery c June 2009
Matsumoto et al Evolving TechnologyFIGURE 3. Immunohistochemical detection of keratinocyte growth factor and keratinocyte growth factor receptor in the remaining lung after trilobectomy.
The expression of keratinocyte growth factor (A, B, and E) and keratinocyte growth factor receptor (C, D, and F) was detected by means of immunohisto-
chemistry. A, Alveolar part at day 4 after trilobectomy. B, Alveolar part at day 4 after the sham operation. C, Alveolar part at day 4 after trilobectomy. D,
Alveolar part at day 4 after the sham operation. E, Bronchial part at day 4 after trilobectomy. F, Bronchial part at day 4 after trilobectomy (Original magni-
fication 4003.) Bar¼ 50 mm. G, Serial changes in the signal density of keratinocyte growth factor staining in the trilobectomy group (n¼ 3, open circles) and
the sham operation group (n ¼ 3, filled circles). H, Serial changes in the signal density of keratinocyte growth factor receptor staining in the trilobectomy
group (n ¼ 3, open circles) and the sham operation group (n ¼ 3, filled circles).E
TEnhancement of KGF Expression and Proliferating
Activity in Cultured Rat Lung Epithelial Cells (L2
Cells) Expressing pKGF–FLAG Gene
L2 cells were transfected with pKGF–FLAG cDNA, and
the concentration of KGF–FLAG protein in the lysates and
culture medium was measured at various time points (Fig-
ure 5, A). KGF concentrations in the medium increased in
a time-dependent manner, whereas those in the lysate were
unchanged.
Next, bromodeoxyuridine (BrdU) uptake by L2 cells
transfected with pKGF-FLAG or pFLAG plasmids was
measured to assess the DNA synthetic activity (Figure 5,
B). After 24 hours of transfection, BrdU uptake increased
significantly in pKGF–FLAG–transfected cells (1.28 
0.04-fold; P¼ .0003), although there was no significant dif-
ference in cell numbers (Figure 5, C). After 72 hours, how-
ever, the increase in cell numbers became significantThe Journal of Thoracic and Ca(pFLAG, 31.3  3.1 3 104 cells; pKGF-FLAG, 42.1 
2.13 104 cells; P ¼ .048) (Figure 5, C), whereas no signif-
icant difference was measured in the rate of BrdU uptake.
These results indicated that the KGF expression vector
used in the present study worked well in lung epithelial cells
and that the expressed KGF was active in stimulating cell
proliferation.
Effect of Augmented KGF Expression Driven by
pKGF–FLAG Transfection on Compensatory
Growth of Remaining Lung After Trilobectomy
PCNAexpressionwas then examined in the remaining lung
transfected with pKGF–FLAG or pFLAG after trilobectomy
to assess the effect of prolonged exposure toKGF on compen-
satory lunggrowthprocess.As shown inFigure 6,A andB, the
number of PCNA-positive cells markedly increased in the re-
maining lung transfected with pKGF–FLAG compared withrdiovascular Surgery c Volume 137, Number 6 1503
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TFIGURE 4. Immunohistochemical detection of keratinocyte growth factor, keratinocyte growth factor receptor, and proliferating cell nuclear antigen in se-
rial sections of the remaining lung at day 4 after trilobectomy. A, Hematoxylin and eosin staining. B, Keratinocyte growth factor was detected in the cytoplasm
of alveolar epithelial cells. C, Proliferating cell nuclear antigen staining. D, Keratinocyte growth factor receptor was detected in the plasma membrane of
alveolar epithelial cells. Proliferating cell nuclear antigen–positive alveolar type II cells are identical, at least in part, to keratinocyte growth factor and ker-
atinocyte growth factor receptor double-positive cells (arrows). Bar ¼ 25 mm.that overexpressing pFLAG alone. In fact, immunohisto-
chemistry of the pKGF–FLAG–transfected lung revealed
a higher abundance of PCNA-positive cells (Figure 6, D)
in areas strongly stained for FLAG (Figure 6, C) than in
FLAG-negative areas (data not shown). Quantitative analy-
sis of PCNA-positive cells also revealed a significant
increase in the remaining lung transfected with pKGF–
FLAG (d2, pFLAG, 10.8  2.1%; pKGF-FLAG, 18.8 
1.1; P ¼ .01, d4, pFLAG, 11.7  0.8%; pKGF-FLAG,
18.4  0.8; P ¼ .005) (Figure 6, E). Figure 6, F, shows
mean linear intercept values measured in the 2 experimental
groups at day 7 after the operation. Rats transfected with the
pKGF–FLAG gene (pFLAG, 57.5 0.9 mm; pKGF-FLAG,
49.1  0.7 mm; P ¼ .001) showed a significant decrease in
the mean values of mean linear intercept compared with rats
transfected with the pFLAG gene.
Finally, PCNA-positive cells in the pKGF–FLAG–trans-
fected lung comprised predominantly alveolar epithelial
cells, with some fibroblasts, endothelial cells, macrophages,
and bronchial epithelial cells. To correlate the PCNA-posi-
tive cells with alveolar epithelial cell type, we double-stained
for PCNA and SP-A (a marker for alveolar type II cells). SP-
A–positive cells also expressed PCNA. Interestingly, how-
ever, some SP-A–negative epithelial cells were also positive
for PCNA, indicating that alveolar type I cells could prolifer-
ate under these experimental conditions (Figure 7). Interest-
ingly, in the remaining lung after trilobectomy only, a few1504 The Journal of Thoracic and Cardiovascular Sucells excluding alveolar type II cells were proliferative (Fig-
ure 1, C). However, in the remaining lung after trilobectomy
andgene transfection,many cells, including type I cells,mac-
rophages, fibroblasts, and bronchial cells, were proliferating,
especially alveolar type II cells (Figure 6, B and D).
DISCUSSION
The present study investigated the possible roles of KGF
in the regulation of rat lung compensatory growth after right
trilobectomy and found that in parallel with more PCNA-
positive alveolar type II cells, the expression levels of
KGF and KGFR were increased in the remaining lung. In
particular, the expression of KGFR was markedly induced
after trilobectomy in alveolar epithelial cells, and such ex-
pression might be involved in the induction of proliferation
of alveolar type II cells. Moreover, when the KGF–FLAG
expression vector was expressed in the remaining lung by
means of electroporation, the fusion protein was effectively
produced in various cells. In addition, the transfected lung
showed significantly enhanced proliferative activity and
possible alveolar septation. These results strongly implicate
KGF in the induction of alveolar epithelial cell proliferation
for compensatory growth of the lung and that in vivo over-
expression of KGF seems to accelerate KGF-dependent
compensatory growth processes in organs.
A number of studies have documented that pulmonary al-
veoli are capable of regeneration. Among rodents, retinoidrgery c June 2009
Matsumoto et al Evolving TechnologyFIGURE 5. Keratinocyte growth factor protein production, DNA synthesis, and cell proliferation in cell medium and lysate transfected with the pKGF–
FLAG gene and the pFLAG gene. A, The concentrations of keratinocyte growth factor in the medium and lysates of L2 cells transfected with the pKGF–
FLAG gene and the pFLAG gene were measured at 24, 48, and 72 hours after transfection. The keratinocyte growth factor concentration in the medium
of L2 cells transfected with the pKGF–FLAG gene increased in a time-dependent manner. B and C, DNA synthesis (B) and cell proliferation (C) of L2 cells
transfected with pKGF–FLAG and pFLAG. L2 cells were transfected by means of electroporation; cultured for 24, 48, and 72 hours; and subsequently as-
sessed for bromodeoxyuridine uptake, as well as the number of cells per well. There were significant differences in bromodeoxyuridine uptake between the
pKGF–FLAG gene and the pFLAG gene at 24 and 48 hours after transfection. There was also a significant difference in the cell numbers between the pKGF–
FLAG gene and the pFLAG gene at 72 hours after transfection.E
Tacid enhanced lung growth after pneumonectomy in rats,1
and estradiol induced alveolar regeneration after loss of al-
veoli induced by ovariectomy in adult mice.14 These studies
described increased cell proliferation, lung volume, lung
weight, alveolar surface density, and alveolar numbers in
experimental animals. Unfortunately, it is impossible to con-
duct the above assessments in human subjects; instead, these
tests are limited to pulmonary function tests, especially mea-
surement of forced vital capacity and forced expiratory vol-
ume in 1 second. Thus there is thus far no documented
evidence for lung regeneration in human subjects. However,
based on the present and previous animal experiments, fur-
ther advances in medical biotechnology could perhaps allow
investigation of this process in human subjects.The Journal of Thoracic and CaThe KGF–KGFR system also plays an important role in
lung epithelial cell turnover in normal rodents. Many studies
showed that administration of recombinant KGF could
mimic the proliferation of alveolar type II cells both in vitro
and in vivo.15,16 Importantly, Kaza and associates5 demon-
strated that recombinantKGF enhances postpneumonectomy
lung growth accompanied by alveolar cell proliferation,
which is similar to the present results. However, they did
not deal with the involvement of KGFR, which is also an es-
sential factor in the logical understanding of the role of KGF
in compensatory lung growth. The present work demon-
strates the involvement of both KGF and KGFR in the induc-
tion of compensatory lung growth. In fact, KGF has been
implicated in various phenomena8,17 in which a low levelrdiovascular Surgery c Volume 137, Number 6 1505
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TFIGURE 6. Effects of pKGF–FLAG gene and pFLAG gene expression on proliferating cell nuclear antigen (PCNA)–positive cells at day 4 after electro-
porative transfection. A and B, Immunohistochemistry for proliferating cell nuclear antigen in the alveolar part of the remaining lung transfected with the
pFLAG gene (A) or the pKGF–FLAG gene (B). C and D, In adjacent sections of the alveolar part transfected with the pKGF–FLAG gene, one section
(C) was used for the detection of FLAG (KGF–FLAG), and another (D) was stained for proliferating cell nuclear antigen expression. (Original magnification
4003.) Bar¼ 50 mm. E, Serial changes in proliferating cell nuclear antigen labeling index.Open bars, Group transfected with the pFLAG gene (n¼ 5); filled
bars, group transfected with the pKGF–FLAG gene (n ¼ 5). *P< .05. F, Mean linear intercept values measured in the remaining lung transfected with the
pFLAG gene or the pKGF-FLAG gene. Values are presented as means standard error of the mean. *P<.001 for comparison of mean linear intercept of the
remaining lung transfected with the pKGF–FLAG gene and that with the pFLAG gene.of constitutive KGFR expression might be sufficient for the
necessary action of KGF. The present study showed that
PCNA, KGF, and KGFR were simultaneously localized in
the same alveolar type II cells at day 4 after trilobectomy.
However, there was an apparent difference in the appearance
of PCNA- and KGFR-positive cells, and it should be noted
that several other factors, such as basic fibroblast growth
factor,18 hepatocyte growth factor (HGF),19,20 epidermal
growth factor,21 and vascular endothelial growth factor,22
might also play a role in lung growth.
Basic fibroblast growth factor induces an increase in pul-
monary blood flow in the damaged lung.18 HGF is a potent
mitogen for rat alveolar epithelial cells, especially alveolar
type II cells,19 and might work simultaneously on various
types of cells. However, HGF alone was found to be incapa-
ble of restoring branching morphogenesis, unlike KGF and
acidic fibroblast growth factor. HGF exhibits synergistic ef-
fects with KGF or acidic fibroblast growth factor in this mes-
enchyme-free system.20 Epidermal growth factor stimulates
the cytodifferentiation of alveolar type II cells and biosyn-
thesis of surfactant precursor proteins.21 Furthermore, it
has been demonstrated that during pulmonary distension,
the stimulus for alveolarization (capillary and alveolar1506 The Journal of Thoracic and Cardiovascular Sugrowth) upregulated vascular endothelial growth factor
mRNA.22 Finally, it is unlikely that each of the above factors
can singularly enhance lung growth; rather, the synergistic
effects of mediators of mesenchymal–epithelial interactions
are more likely to be important in lung growth.
The present study applied electroporation to maximize the
transfection efficiency so that a single-dose regimen could
be used and much smaller amounts of DNA would be re-
quired. One major advantage of electroporation for gene
transfection into the lung is that it efficiently transfers
cDNA to multiple cell types simultaneously, including alve-
olar epithelial cells, bronchial epithelial cells, smooth mus-
cle cells, endothelial cells, and other cells in focal or target
areas of the lung. In the present study, in the remaining
lung after trilobectomy only, a few cells, excluding alveolar
type II cells, were proliferative (Figure 1,C); however, in the
remaining lung after trilobectomy and gene transfection,
many cells, including type I cells, macrophages, fibroblasts,
and bronchial cells, were proliferative, especially alveolar
type II cells (Figure 6, B and D).
The significantly increased PCNA index in the remaining
lung after trilobectomy was seen by day 2 after transfection
and continued until day 4 before returning to the controlrgery c June 2009
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Tuntransfected level at day 7. Yew and coworkers23 reported
increased duration of expression of up to 3months with a hu-
man ubiquitin B promoter or a hybrid cytomegalovirus–
ubiquitin B promoter. In the present study we are not sure
whether a long-term expression of KGF is beneficial. How-
ever, these alternative promoters might be tested for their ef-
fects on both the duration and level of gene expression in our
system. On the other hand, at day 7 after the operation, rats
transfected with the pKGF–FLAG gene showed a significant
decrease in the mean values of mean linear intercept com-
pared with rats transfected with the pFLAG gene (P <
.001). In spite of the short duration of gene expression, these
data support the possibility of alveolar septation and in-
creased number of alveoli in the pulmonary parenchyma.
In conclusion, our results showed the potential involve-
ment of endogenous KGF in compensatory tissue growth
in adult rat lungs. Moreover, direct injection of naked
DNA coupled with electroporation seemed to significantly
enhance compensatory lung growth. Although more work
needs to be done, we believe this study advocates gene ther-
apy as a potential tool to accelerate tissue growth in adult rat
lungs.
We thank Dr Jeffrey S. Rubin from the National Cancer Insti-
tute/CCR/LCMB, for providing the human KGF cDNA construct.
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